Andrew D Redd
Overview
Explore the profile of Andrew D Redd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
3515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mumby M, Prodger J, Hackman J, Saraf S, Zhu X, Ferreira R, et al.
Lancet Microbe
. 2025 Mar;
:101018.
PMID: 40088911
Background: The persistence of a replication-competent latent viral reservoir (RC-LVR) during antiretroviral therapy (ART) is a barrier to the development of a cure for HIV-1, but the role of viral...
2.
Epstein-Shuman A, Zhu X, Hunt J, Fernandez R, Rozek G, Redd A, et al.
J Infect Public Health
. 2025 Mar;
18(6):102722.
PMID: 40086141
Objective: Autoantibodies (AAbs) to interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1, have been associated with COVID-19 severity. Despite relatively low COVID-19 morbidity and mortality in East and...
3.
Sulaiman A, Sengsouk I, White J, Marshall C, Fernandez R, Redd A, et al.
Transfusion
. 2025 Jan;
PMID: 39844430
Background: The Association for the Advancement of Blood and Biotherapies guidelines recommend the use of high-titer COVID-19 convalescent plasma (CCP) for patients with SARS-CoV-2 at high risk of disease progression,...
4.
Durand C, Segev D, Redd A
N Engl J Med
. 2025 Jan;
392(2):204-205.
PMID: 39778178
No abstract available.
5.
Ismail S, Sebaa S, Abrahams B, Nason M, Mumby M, Dikeakos J, et al.
bioRxiv
. 2024 Nov;
PMID: 39554110
HIV-1 Nef mediates immune evasion and viral pathogenesis in part through downregulation of cell surface cluster of differentiation 4 (CD4) and major histocompatibility complex class I (MHC-I) on infected cells....
6.
Epstein-Shuman A, Hunt J, Caturegli P, Winguth P, Fernandez R, Rozek G, et al.
Int J Infect Dis
. 2024 Nov;
150:107289.
PMID: 39489282
Introduction: Autoantibodies (AAbs) directed against interferon alpha (aIFNα), nuclear antigens (ANAs), anti-cardiolipin (aCL), and anti-beta 2 glycoprotein 1 (aβ2GP1), have been demonstrated to significantly correlate with the severity of acute...
7.
Durand C, Massie A, Florman S, Liang T, Rana M, Friedman-Moraco R, et al.
N Engl J Med
. 2024 Oct;
391(15):1390-1401.
PMID: 39413376
Background: Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ...
8.
Durand C, Redd A
J Clin Invest
. 2024 Oct;
134(20).
PMID: 39403922
Kidney transplantation from donors with HIV to recipients with HIV (HIV D+/R+) is an emerging practice that has shown substantial clinical benefit. Sustained HIV superinfection, whereby a transplant recipient acquires...
9.
Kim S, Kigozi G, Martin M, Galiwango R, Quinn T, Redd A, et al.
Virus Evol
. 2024 Oct;
10(1):veae065.
PMID: 39399152
There is limited data on human immunodeficiency virus (HIV) evolutionary trends in African populations. We evaluated changes in HIV viral diversity and genetic divergence in southern Uganda over a 24-year...
10.
Hussey H, Vreede H, Davies M, Heekes A, Kalk E, Hardie D, et al.
PLOS Glob Public Health
. 2024 Aug;
4(8):e0003554.
PMID: 39106267
In low- and middle-income countries where SARS-CoV-2 testing is limited, seroprevalence studies can help describe and characterise the extent of the pandemic, as well as elucidate protection conferred by prior...